FDA Seeks Panel Expert Review Of Antibiotic
An experimental antibiotic developed by drugmaker Theravance Inc. to treat complicated skin infections may cause possible kidney damage, birth defects and death, according to the U.S. Food and Drug Administration's review...To view the full article, register now.
Already a subscriber? Click here to view full article